点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome)):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017349)
◆英語タイトル:Infantile Spasm (West Syndrome)-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017349
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome)):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界における点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))の概要

・点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Infantile Spasm (West Syndrome)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Infantile Spasm (West Syndrome). This report provides information on the therapeutic development based on the Infantile Spasm (West Syndrome) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Infantile Spasm (West Syndrome)
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Infantile Spasm (West Syndrome) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Infantile Spasm (West Syndrome) and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Infantile Spasm (West Syndrome)
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Infantile Spasm (West Syndrome) pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Infantile Spasm (West Syndrome) Overview
• Infantile Spasm (West Syndrome) Pipeline Therapeutics
• Infantile Spasm (West Syndrome) Therapeutics under Development by Companies
• Infantile Spasm (West Syndrome) Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Infantile Spasm (West Syndrome) Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Infantile Spasm (West Syndrome) Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Infantile Spasm (West Syndrome) Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Infantile Spasm (West Syndrome) – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Infantile Spasm (West Syndrome) – Discontinued Products
• Infantile Spasm (West Syndrome) – Dormant Products
• Companies Involved in Therapeutics Development for Infantile Spasm (West Syndrome)
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Infantile Spasm (West Syndrome), 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Infantile Spasm (West Syndrome) Assessment by Monotherapy Products
• Infantile Spasm (West Syndrome) Assessment by Combination Products
• Infantile Spasm (West Syndrome) Assessment by Route of Administration
• Infantile Spasm (West Syndrome) Assessment by Stage and Route of Administration
• Infantile Spasm (West Syndrome) Assessment by Molecule Type
• Infantile Spasm (West Syndrome) Assessment by Stage and Molecule Type
• Infantile Spasm (West Syndrome) Therapeutics – Discontinued Products
• Infantile Spasm (West Syndrome) Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Infantile Spasm (West Syndrome), 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Infantile Spasm (West Syndrome) Assessment by Monotherapy Products
• Infantile Spasm (West Syndrome) Assessment by Combination Products
• Infantile Spasm (West Syndrome) Assessment by Route of Administration
• Infantile Spasm (West Syndrome) Assessment by Stage and Route of Administration
• Infantile Spasm (West Syndrome) Assessment by Molecule Type
• Infantile Spasm (West Syndrome) Assessment by Stage and Molecule Type


*** レポートのキーワード ***

点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome))、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • メイクアップ化粧品市場の展望(~2017):アイルランド(市場規模、流通・ブランドシェア、主要イベント、競争環境)
    ※当レポートはアイルランドのメイクアップ化粧品製品の消費トレンド、市場規模(過去、予測)、ブランドシェア、販売チャネル、関連企業プロフィール、業界のM&A動向を含む最新ニュースなどをまとめました。 ■Product Synopsis "The Future of the Make-up Market in Ireland to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape" is the result of Canadean's extensive market and …
  • 世界のHDPE合成紙市場2015
    The Global HDPE Synthetic Paper Industry 2015 Market Research Report is a professional and in-depth study on the current state of the HDPE Synthetic Paper industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. …
  • 連続表示用露点計の世界市場2018
    Continuous Indicating Dew Point Meter Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries …
  • インテリジェント・モーター・コントローラの世界市場2015
    The Global Intelligent Motor Controller Industry Report 2015 is a professional and in-depth study on the current state of the Intelligent Motor Controller industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. …
  • 産業用バーナーの世界市場2016-2020
    About Industrial Burner In the manufacturing sector, industrial process heating operations account for a major part of the energy demand, accounting for approximately 70% of the manufacturing sector's process energy end use. Boilers are pressure vessels that are designed to either heat water or prod …
  • 世界のホイールバランサー市場2015
    The Global Wheel Balancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Wheel Balancer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Wheel Ba …
  • 認知症(Dementia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)
    SUMMARY DelveInsight’s Report, “Dementia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dementia Report is to u …
  • 世界及び中国のトランスオイル市場
    Global and Chinese Transformer oil Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Transformer oil industry. The report firstly reviews the basic information of Transformer oil including its classification, application and manufacturing t …
  • Fungal Infections:パイプライン分析(ヘルスケア市場レポート)H1 2013
    Fungal Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Fungal Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Fungal Infections, complete with latest upd …
  • DPaaS(データ保護サービス)の世界市場2015-2019
    About DPaaS Organizations use data protection as a service (DPaaS) to protect business data both in transit and at rest. DPaaS tools, with the support of VPN, are used to aid in remote security. Small and big vendors are capitalizing on the market opportunity by offering various services, including …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017349 )"点頭てんかん(ウエスト症候群)(Infantile Spasm (West Syndrome)):治療薬開発パイプライン動向2014" (英文:Infantile Spasm (West Syndrome)-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。